Stockreport

Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients [Yahoo! Finance]

Monopar Therapeutics Inc.  (MNPR) 
PDF developing innovative treatments for cancer patients, today announced that its Phase 1 dosimetry clinical trial for its novel radiopharmaceutical imaging agent MNPR-101- [Read more]